Mesoblast (MESO) Change in Accured Expenses (2017 - 2025)

Mesoblast has disclosed Change in Accured Expenses across 9 years of filings, most recently posting -$1.9 million for Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at -$1.9 million, up 91.21% year-over-year; the trailing twelve-month figure through Dec 2025 was -$43.9 million (down 115.72% YoY), and the FY2025 annual result was -$21.9 million, down 1302.25% from the prior year.
• Change in Accured Expenses came in at -$1.9 million for Q4 2025 at Mesoblast, up from -$21.9 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.8 million in Q2 2024 to a low of -$21.9 million in Q4 2024.
• The 5-year median for Change in Accured Expenses is -$234000.0 (2022), against an average of -$3.2 million.
• Across the five-year window, Change in Accured Expenses surged 878.21% in 2024 and sank 1302.25% in 2025, its largest moves.
• Mesoblast's Change in Accured Expenses stood at $44000.0 in 2021, then tumbled by 631.82% to -$234000.0 in 2022, then changed by 0.0% to -$234000.0 in 2023, then tumbled by 9255.98% to -$21.9 million in 2024, then soared by 91.21% to -$1.9 million in 2025.
• The last three Change in Accured Expenses figures came in at -$1.9 million (Q4 2025), -$21.9 million (Q2 2025), and -$21.9 million (Q4 2024), per Business Quant data.